Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3Pulmonary Disease, Chronic Obstructive 1Obesity 1Lung Neoplasms 1Insulin Resistance 1Disease 1Diabetes Mellitus, Type 2 1

Interventions

Metformin 18Inositol 5Exercise 4Pioglitazone 3Insulin 3Ethinyl Estradiol 3drospirenone and ethinyl estradiol combination 2Surveys and Questionnaires 2Cyproterone Acetate 2Acupuncture Therapy 2ziprasidone 1salicylsalicylic acid 1maltodextrin 1licogliflozin 1exendin (9-39) 1drospirenone 1cinnulin PF 1Zoledronic Acid 1Waist-Hip Ratio 1Waist Circumference 1Vitamin D 1Time 1Thioctic Acid 1Tablets 1Sulfasalazine 1Sugars 1Sodium-Glucose Transporter 2 Inhibitors 1Sodium Salicylate 1Saline Solution 1Resistance Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Insulin Resistance × Sodium-Glucose Transporter 2 Inhibitors × Clear all
NCT04700839 2022-09-10

PCOS

Shanghai 10th People's Hospital

Phase 4 Completed
68 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡